Shanghai Henlius Biotech shares soar in Hong Kong after Fosun’s US$690 million buyout offer
Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.
Henlius joins a wave of companies that have left Hong Kong’s stock market this year, either through privatisation or voluntary delisting having found themselves undervalued.